传统的分成型选择性节点辐射与低分成型协议相比,保持了早期抗瘤免疫力和有效性
Genki Edward Sato1, Tsubasa Watanabe2, Michio Yoshimura1
1Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
International journal of radiation oncology, biology, physics
|October 2, 2025
概括
传统的分成型选择性节点辐射 (ENI) 可能对瘤免疫力的影响小于低分成型ENI. 低分离ENI与传统分离ENI相比,显示出劣质的抗瘤作用和减少瘤透的淋巴细胞.
科学领域:
- 辐射瘤学 辐射瘤学
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 选择性节点辐射 (ENI) 用于癌症治疗.
- 临床ENI通常使用常规分化.
- 动物研究经常使用低分数的ENI协议,可能与临床实践有所不同.
研究的目的:
- 评估ENI剂量分成对瘤免疫力的影响.
- 在小鼠模型中评估ENI分离对抗瘤疗效的影响.
- 为了比较常规分成的ENI (Conv-ENI) 与低分成的ENI (Hypo-ENI).
主要方法:
- 脊髓细胞被辐射以评估放射敏感性和免疫功能.
- 在MC38和SCC7瘤模型中,没有接受ENI,Conv-ENI (2 Gy × 8分数),或Hypo-ENI (9.8 Gy × 1分数).
- 对瘤反应,免疫细胞透和淋巴细胞群体进行了纵向分析,使用FTY720评估淋巴细胞贩运.
主要成果:
- 低分离ENI (Hypo-ENI) 与常规分离ENI (Conv-ENI) 相比,显示出较差的抗瘤作用.
- 与Conv-ENI相比,Hypo-ENI显著减少了CD8+瘤透淋巴细胞和血液淋巴细胞.
- 高剂量辐射 (9.8 Gy) 损害了淋巴细胞活力和免疫功能,与较低剂量 (≤3 Gy) 不同.
结论:
- 传统的分成型ENI可能对瘤免疫力产生不那么严重的负面影响,而不是以前的低分成型研究.
- 不同的ENI分成方案可能会对淋巴细胞贩运和抗瘤免疫产生不同的影响.
- 需要进一步的研究来阐明传统与低分化ENI对癌症免疫力的差异性影响.
相关概念视频
Cancer Stem Cells and Tumor Maintenance
4.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K


